HELLP Syndrome: Clinical Trials

5 trials for HELLP Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 not yet recruiting, 1 unknown, 1 withdrawn. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Completed 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 21Withdrawn 1

Follow HELLP Syndrome: new trials by email Literature Review of HELLP Syndrome trials Research Report on HELLP Syndrome

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preeclampsia Intervention Netherlands
Metformin Hydrochloride, Placebo - Pre-Eclampsia Onset Less Than 37 Weeks, Pre-Eclampsia
Phase 3Not yet recruitingAmsterdam UMC1802024-08-012024-06-11
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
labetalol (seizure prevention), MgSO4 (seizure prevention) - Preeclampsia, Pregnancy Induced Hypertension
Phase 2 / Phase 3WithdrawnBaylor College of Medicine2015-06-012017-01-13
Dexamethasone Efficacy in HELLP I Syndrome
Dexamethasone, sterile water - HELLP Syndrome
Phase 3UnknownUniversidad del Valle, Colombia1602009-10-012010-06-07
RCT of Antioxidant Therapy to Prevent Preeclampsia in Brazil
Vitamin C and E - Preeclampsia, Eclampsia
Phase 3CompletedNICHD Global Network for Women's and Children's Health7342003-07-012013-11-25
Calcium for Pre-Eclampsia Prevention (CPEP)
calcium, dietary supplements - Cardiovascular Diseases, Eclampsia
Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1991-03-012017-03-13

Narrower conditions

Pre-Eclampsia (4)  ·  Eclampsia (3)  ·  Hypertension (2)  ·  Premature Birth (2)  ·  Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Hypertension, Pregnancy-Induced (1)  ·  Pregnancy Complications (1)  ·  Seizures (1)  ·  Vascular Diseases (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (5)  ·  Urogenital Diseases (5)  ·  Hypertension, Pregnancy-Induced (4)  ·  Pregnancy Complications (4)  ·  Obstetric Labor Complications (2)  ·  Obstetric Labor, Premature (2)  ·  Cardiovascular Diseases (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Ascorbic Acid (1)  ·  Calcium (1)  ·  Dexamethasone (1)  ·  Dietary Supplements (1)  ·  Labetalol (1)  ·  Metformin (1)

Sponsors

Amsterdam UMC (1)  ·  Baylor College of Medicine (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  NICHD Global Network for Women's and Children's Health (1)  ·  Universidad del Valle, Colombia (1)

Countries

Brazil (1)  ·  Colombia (1)  ·  India (1)  ·  United States (1)

Top investigators

Baha Sibai (1)  ·  Cynthia Morris (1)  ·  Javier Fonseca, Dr (1)  ·  John Hauth (1)  ·  Joseph A. Spinnato, M.D. (1)  ·  Luis Curet (1)  ·  Michael A Belfort, MD, PhD (1)  ·  Patrick Catalano (1)  ·  R.C. Painter, Prof, MD, PhD (1)

Results publications

PMID 18055726, PMID 18928997

NIH funding

2023 (1), U01HD040565 (1)